HCAT logo

Health Catalyst, Inc. Stock Price

NasdaqGS:HCAT Community·US$200.6m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author

HCAT Share Price Performance

US$2.78
-5.07 (-64.59%)
53.7% undervalued intrinsic discount
US$6.00
Fair Value
US$2.78
-5.07 (-64.59%)
53.7% undervalued intrinsic discount
US$6.00
Fair Value
Price US$2.78
AnalystHighTarget US$6.00
AnalystConsensusTarget US$4.56
AnalystLowTarget US$3.50

HCAT Community Narratives

AnalystHighTarget·
Fair Value US$6 52.5% undervalued intrinsic discount

Accelerating AI Adoption And Digital Transformation Will Expand Healthcare Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$4.56 37.4% undervalued intrinsic discount

Modular AI Solutions Will Transform Value-Based Healthcare

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AnalystLowTarget·
Fair Value US$3.5 18.6% undervalued intrinsic discount

Medicaid Cuts Will Constrict Deals But Spur Efficiency

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent HCAT News & Updates

Health Catalyst, Inc. (NASDAQ:HCAT) Just Reported Earnings, And Analysts Cut Their Target Price

Aug 13
Health Catalyst, Inc. (NASDAQ:HCAT) Just Reported Earnings, And Analysts Cut Their Target Price

Health Catalyst, Inc. Key Details

US$316.1m

Revenue

US$170.7m

Cost of Revenue

US$145.4m

Gross Profit

US$245.5m

Other Expenses

-US$100.1m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-1.42
Gross Margin
46.00%
Net Profit Margin
-31.67%
Debt/Equity Ratio
44.0%

Health Catalyst, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet and fair value.

3 Risks
1 Reward

About HCAT

Founded
2008
Employees
1500
CEO
Daniel Burton
WebsiteView website
www.healthcatalyst.com

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments, Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, ACOs, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

U.S. Market Performance

  • 7 Days: 0.8%
  • 3 Months: 8.3%
  • 1 Year: 17.8%
  • Year to Date: 15.4%
The Utilities sector gained 3.1% while the market remained flat over the last week. As for the longer term, the market has risen 18% in the past 12 months. Looking forward, earnings are forecast to grow by 15% annually. Market details ›